ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

RNLX Renalytix PLC

0.4445
0.0089 (2.04%)
最終更新日: 03:08:21
15分遅延
名称 銘柄コード 市場 種別
Renalytix PLC RNLX NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.0089 2.04% 0.4445 03:08:21
始値 安値 高値 終値 前日終値
0.45 0.423 0.4524 0.4356
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1523:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1522:23EDGAR2Form 8-K - Current report
2024/5/1520:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1520:00EDGAR2Form 8-K - Current report
2024/5/1520:00GLOBERenalytix Reports Financial Results for Third Quarter of..
2024/5/0920:00GLOBERenalytix to Report Financial Results for Third Quarter..
2024/4/0820:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
2024/3/1420:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
2024/2/1521:00GLOBERenalytix Reports Financial Results for Second Quarter of..
2024/2/1521:00EDGAR2Form 8-K - Current report
2024/2/1506:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/0923:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
2024/1/1721:15EDGAR2Form 8-K - Current report
2024/1/1021:15EDGAR2Form 8-K - Current report
2024/1/1021:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
2023/12/3006:02EDGAR2Form 8-K - Current report
2023/11/1806:01EDGAR2Form ARS - Annual Report to Security Holders
2023/11/1421:00GLOBERenalytix Reports Financial Results for First Quarter of..
2023/11/0721:00GLOBERenalytix to Report Financial Results for First Quarter..
2023/11/0405:04EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/2421:00EDGAR2Form 8-K - Current report
2023/10/0620:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
2023/9/2820:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
2023/9/2520:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
2023/9/0905:04EDGAR2Form 8-K - Current report
2023/9/0720:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
2023/8/0320:00GLOBERenalytix Clinical Advisory Board Formed to Support..
2023/7/2120:00GLOBERenalytix Announces Middle East Distribution Agreement with..
2023/7/0720:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
2023/7/0320:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
2023/6/3007:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
2023/6/3007:01GLOBEFDA Grants De Novo Marketing Authorization for..
2023/6/1520:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
2023/6/0920:00GLOBERenalytix Reports Financial Results for Third Quarter of..
2023/6/0520:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
2023/5/2520:00GLOBERenalytix selects EVERSANA® to expand commercialization of..

最近閲覧した銘柄

Delayed Upgrade Clock